Third Harmonic Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell THRD and other ETFs, options, and stocks.

About THRD

Third Harmonic Bio, Inc. develops pharmaceutical products for the treatment of allergic and immune diseases and disorders. It focuses on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases. 

CEO
Natalie C. Holles
CEONatalie C. Holles
Employees
53
Employees53
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
2019
Founded2019
Employees
53
Employees53

THRD Key Statistics

Market cap
245.04M
Market cap245.04M
Price-Earnings ratio
-4.37
Price-Earnings ratio-4.37
Dividend yield
Dividend yield
Average volume
246.11K
Average volume246.11K
High today
High today
Low today
Low today
Open price
$5.45
Open price$5.45
Volume
0.00
Volume0.00
52 Week high
$16.02
52 Week high$16.02
52 Week low
$3.18
52 Week low$3.18

People also own

Based on the portfolios of people who own THRD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.